BioLife Solutions to Report First Quarter 2022 Financial Results and Provide Business Update on May 9, 2022

Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS) will release its first quarter 2022 financial results after the market closes on May 9, 2022. A conference call will follow at 4:30 PM ET, where management will discuss financials and provide a business update. BioLife Solutions is recognized for its innovative bioproduction tools and services tailored for the cell and gene therapy sectors. To access the call, visit their Investor Relations page or dial in at (877) 270-2148 domestically.

Positive

• Anticipated financial results and business update may indicate positive performance.
• BioLife Solutions' strong reputation in bioproduction tools presents growth opportunities.

Negative

• None.

BOTHELL, Wash., May 2, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter 2022 financial results will be released after market close on Monday, May 9^th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day.  Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free (877) 270-2148 for domestic callers and (412) 902-6510 for international callers. No passcode is required for the live call. A webcast replay will be available approximately two hours after the call and will be archived on https://www.biolifesolutions.com/ for 90 days.

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system,  high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

Contact Information:

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2022-financial-results-and-provide-business-update-on-may-9-2022-301537829.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions report its first quarter 2022 financial results?

BioLife Solutions will report its first quarter 2022 financial results after market close on May 9, 2022.

What time is the BioLife Solutions conference call?

The conference call will take place at 4:30 PM ET on May 9, 2022.

How can I access the BioLife Solutions earnings call?

You can access the call via the Investor Relations page at www.biolifesolutions.com or by calling (877) 270-2148 for domestic callers.